Erratum To: Inhibition of Triclabendazole Metabolism in Vitro by Ketoconazole Increases Disruption to the Tegument of a Triclabendazole-Resistant Isolate of Fasciola Hepatica

Parasitology Research - Germany
doi 10.1007/s00436-011-2554-6
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Exploring the Fasciola Hepatica Tegument Proteome

International Journal for Parasitology
ParasitologyInfectious Diseases
2011English

Lack of Efficacy of Triclabendazole Against Fasciola Hepatica Is Present on Sheep Farms in Three Regions of England, and Wales

Veterinary Record
MedicineVeterinary
2019English

Tautomeric Polymorphism in Triclabendazole

Acta Crystallographica Section A Foundations of Crystallography
2011English

P131 Efficacy of Triclabendazole Treatment on Fascioliasis

Medical Entomology and Zoology
2001English

Epidemiology of Fasciola Hepatica in Iran

International Journal of Biology
2012English

Anthelmintic and Toxicological Assessment of Supramolecular Triclabendazole Complexes

Meditsinskaya Parazitologiya i Parazitarnye Bolezni
MedicineParasitology
2018English

Effects of Ketoconazole on Cyclophosphamide Metabolism: Evaluation of CYP3A4 Inhibition Effect Using the in Vitro and in Vivo Models

Experimental Animals
GeneticsMolecular BiologyBiochemistryVeterinaryAnimal ScienceMedicineZoology
2018English

Antibody-Dependent Cell-Mediated Cytotoxicity to Newly Excysted Juvenile Fasciola Hepatica in Vitro Is Mediated by Reactive Nitrogen Intermediates

Parasite Immunology
ParasitologyImmunology
2001English

In Vitro Selection of Mutant HDM2 Resistant to Nutlin Inhibition

PLoS ONE
Multidisciplinary
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy